阻塞性缩性心肌病变:病理生理学和诊断
Miguel Marques Antunes1,2,3, José Miguel Viegas1, Vera Vaz Ferreira1
1Serviço de Cardiologia, Hospital de Santa Marta, Centro Clínico Académico de Lisboa (CCAL), Lisbon, Portugal.
Indian journal of thoracic and cardiovascular surgery
|January 30, 2026
概括
增高性心肌病 (HCM) 是一种遗传性心脏病,导致左心室 (LV) 增高和输出管道阻塞. 使用先进成像的全面评估对于个性化治疗策略至关重要.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 医疗成像医学成像
背景情况:
- 增高性心肌病变 (HCM) 是一种遗传性心脏疾病,其特征是左心室 (LV) 增高.
- 阻塞性HCM涉及结构异常,如隔膜缩和中枢问题.
- 病理生理学包括超收缩性,肌细胞乱,纤维化和冠状动脉微血管功能障碍.
研究的目的:
- 审查在阻塞性HCM中遗传,结构和功能元素的复杂相互作用.
- 强调全面评估对有效治疗决策的重要性.
主要方法:
- 诊断整合了临床表现,体检,心电图,遗传检测和高级成像.
- 胸外回声心脏图是评估缩,LVOT梯度和门功能的主要工具.
- 心脏MRI补充了回声心脏学以解剖细节,LV质量量定量和纤维化检测.
主要成果:
- 诊断HCM依赖于整合多种临床和成像模式.
- 心声图和心脏MRI对于HCM的详细评估至关重要.
- 先进的成像技术有助于识别特定的模式和纤维化,指导治疗.
结论:
- 了解阻塞性HCM的多面性质是关键.
- 综合诊断评估对于量身定制患者管理至关重要.
- 个性化治疗策略可以改善阻塞性HCM的结果.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
486
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
486
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
Cardiomyopathy II: Dilated Cardiomyopathy
563
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
563
Cardiomyopathy IV: Restrictive Cardiomyopathy
532
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Cardiomyopathy V: Interprofessional Care
442
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification
603
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
603


